Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine

ChemMedChem

Volumn 3, Issue 5, 2008, Pages 737-741

  Renaudet, Olivier ^a   BenMohamed, Lbachir ^b   Dasgupta, Gargi ^b   Bettahi, Ilham ^b   Dumy, Pascal ^a  

^a UNIVERSITÉ JOSEPH FOURIER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigens; Antitumor agents; Chemoselectivity; Glycopeptide; Lipopeptide

Indexed keywords

CANCER VACCINE; EPITOPE; GLYCOPEPTIDE; RECOMBINANT VACCINE; TUMOR ANTIGEN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; HUMAN; IMMUNIZATION; IMMUNOLOGY; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CANCER VACCINES; CELL LINE, TUMOR; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GLYCOPEPTIDES; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; VACCINES, SYNTHETIC;

EID: 47649099501     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200700315     Document Type: Article

References (45)

1. a) S. Hakomori, Annu. Rev. Immunol. 1984, 2, 103-126;
2. b) T. Feizi, R. A. Childs, Trends Biochem. Sci. 1985, 10, 24-29;
3. c) G. F. Springer, J. Mol. Med. 1997, 75, 594-602.
4. a) G. Ragupathi, Cancer Immunol. Immunother. 1996, 43, 152-157;
5. b) S. J. Danishefsky, Allen J. R. , Angew. Chem. 2000, 112, 882-912;
6. Angew. Chem. Int. Ed. 2000, 39, 836-863;
7. c) S. F. Slovin, S. J. Keding, G. Ragupathi, Immunol. Cell Biol. 2005, 83, 418-428;
8. d) C. Mesa, L. E. Fernandez, Immunol. Cell Biol. 2004, 82, 644-650.
9. For selected publications, see: a) H. Kunz, S. Birnbach, Angew. Chem. 1986, 98, 354-355;
10. Angew. Chem. Int. Ed. Engl. 1986, 25, 360-362;
11. b) F. Helling, A. Shang, M. Calves, S. Zhang, S. Ren, R. K. Yu, H. F. Oettgen, P. O. Livingston, Cancer Res. 1994, 54, 197-203;
12. c) S. D. Kuduk, J. B. Schwarz, X.-T. Chen, P. W. Glunz, D. Sames, G. Ragupathi, P. O. Livingston, S. J. Danishefsky, J. Am. Chem. Soc. 1998, 120, 12474-12485;
13. d) S. F. Slovin, G. Ragupathi, C. Musselli, K. Olkiewicz, D. Verbel, S. D. Kuduk, J. B. Schwarz, D. Sames, S. Danishefsky, P. O. Livingston, H. I. Scher, J. Clin. Oncol. 2003, 21, 4292-4298;
14. e) S. Dziadek, D. Kowalczyk, H. Kunz, Angew. Chem. 2005, 117, 7798-7803;
15. Angew. Chem. Int. Ed. 2005, 44, 7624-7630.
16. For selected publications, see: a) S. Bay, R. Lo-Man, E. Osinaga, H. Nakada, C. Leclerc, D. CantacuzQne, J. Pept. Res. 1997, 49, 620-625;
17. b) R. Lo-Man, S. Bay, S. Vichier-Guerre, E. DRriaud, D. Cantacuzène, C. Leclerc, Cancer Res. 1999, 59, 1520-1524;
18. c) R. Lo-Man, S. Vichier-Guerre, R. Perraut, E. Dériaud, V. Huteau, L. BenMohamed, O. M. Diop, P. O. Livingston, S. Bay, C. Leclerc, Cancer Res. 2004, 64, 4987-4994.
19. G. A. Pietersz, D. S. Pouniotis, V. Apostolopoulos, Curr. Med. Chem. 2006, 13, 1591-1607.
20. X. Zhang, A. Issagholian, E. A. Berg, J. B. Fishman, A. B. Nesburn, L. Ben-Mohamed, J. Virol. 2005, 79, 15289-15301.
21. L. BenMohamed, S. L. Wechsler, A. B. Nesburn, Lancet Infect. Dis. 2002, 2, 425-431.
22. a) D. C. Jackson, Y. F. Lau, T. Le, A. Suhrbier, G. Deliyannis, C. Cheers, C. Smith, W. Zeng, L. E. Brown, Proc. Natl. Acad. Sci. USA 2004, 101, 15440-15445;
23. b) T. Buskas, S. Ingale, G.-J. Boons, Angew. Chem. 2005, 117, 6139-6142;
24. Angew. Chem. Int. Ed. 2005, 44, 5985-5988;
25. c) S. Ingale, M. A. Wolfert, J. Gaekwad, T. Buskas, G.-J. Boons, Nature Chem. Biol. 2007, 3, 663-667.
26. For recent reviews, see: a) O. Seitz, I. Heinemann, A. Mattes, H. Waldmann, Tetrahedron 2001, 57, 2247-2277;
27. b) A. Liakatos, H. Kunz, Curr. Opin. Mol. Ther. 2007, 9, 35-44;
28. c) D. P. Galonić, D. Y. Gin, Nature 2007, 446, 1000-1007;
29. d) P. H. Seeberger, D. B. Werz, Nature 2007, 446, 1046-1051.
30. a) J. P. Tam, Q. Yu, Y.-A. Lu, Biologicals 2001, 29, 189-196;
31. b) H. Gras-Masse, Biologicals 2001, 29, 183-188;
32. c) C. Grandjean, C. Rommens, H. Gras-Masse, O. Melnyk, Angew. Chem. 2000, 112, 1110-1114;
33. Angew. Chem. Int. Ed. 2000, 39, 1068-1072;
34. d) G.-A. Cremer, N. Bureaud, D. Lelièvre, V. Piller, F. Piller, A. Delmas, Chem. Eur. J. 2004, 10, 6353-6360.
35. M. Mutter, P. Dumy, P. Garrouste, C. Lehmann, M. Mathieu, C. Peggion, S. Peluso, A. Razaname, G. Tuchscherer, Angew. Chem. 1996, 108, 1588-1591;
36. Angew. Chem. Int. Ed. Engl. 1996, 35, 1482-1485.
37. a) D. Boturyn, J.-L. Coll, E. Garanger, M.-C. Favrot, P. Dumy, J. Am. Chem. Soc. 2004, 126, 5730-5739;
38. b) O. Renaudet, P. Dumy, Org. Lett. 2003, 5, 243-246.
39. S. Grigalevicius, S. Chierici, O. Renaudet, R. Lo-Man, E. Dériaud, C. Leclerc, P. Dumy, Bioconjugate Chem. 2005, 16, 1149-1159.
40. O. Renaudet, P. Dumy, Org. Biomol. Chem. 2006, 4, 2628-2636.
41. B. Ponsati, M. Ruiz-Gayo, E. Giralt, F. Albericio, D. Andreu, J. Am. Chem. Soc. 1990, 112, 5345-5347.
42. O. Rötzschke, K. Falk, S. Stevanovic, G. Jung, P. Walden, H.-G. Rammensee, Eur. J. Immunol. 1991, 21, 2891-2894.
43. J. Alexander, J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H. M. Serra, R. T. Kubo, A. Sette, H. M. Grey, Immunity 1994, 1, 751-761.
44. Manuscript in preparation.
45. C. Fayolle, D. Ladant, G. Karimova, A. Ullmann, C. Leclerc, J. Immunol. 1999, 162, 4157-4162.